BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma...

Acute Lung Injury Market Size to Outstrip $741.98Mn by 2028 Growth Projections at 4.7% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Acute Lung Injury Market: Key InsightsAccording to our new research study on "Acute Lung Injury Market to 2028 – Global Analysis and Forecast – by...

New H.265 hybrid set-top box chipset from ALi Corp. gets a boost with MIPS CPUs LONDON and TAIPEI, Taiwan, June 22, 2016 (GLOBE NEWSWIRE) -- Imagination Technologies (IMG.L) announces that ALi Corporation, a leading set-top box (STB) chipset provider, is shipping a...

Low-Income Older Adults More Likely to Develop Heart Failure Study Highlights: Older adults with low income are at increased risk for heart failure. Income status better predicts who develops heart failure than education level. Despite Medicare...